Drug intelligence / Profile preview

Haporine-S (cyclosporine)

Development stage
Phase 3
Lead developer
DH Bio
Modality
Small Molecules, Peptides
Administration
Ophthalmic
01

Overview

Haporine-S is an ophthalmic nanoemulsion formulation of cyclosporine developed by DH Bio Co., Ltd. for the treatment of moderate to severe dry eye disease (keratoconjunctivitis sicca). Cyclosporine is a calcineurin inhibitor that acts as an immunosuppressant by inhibiting T-cell activation and decreasing the production of pro-inflammatory cytokines. By reducing inflammation on the ocular surface and in the lacrimal glands, it helps to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation. Haporine-S was evaluated in a Phase III clinical trial in South Korea to demonstrate non-inferiority to the reference product, Restasis, and subsequently received regulatory approval in South Korea.

Brand names
Haporine-S
02

Targets

CN (Calcineurin)Cyp (Cyclophilin family)PPIA (Peptidyl-prolyl cis-trans isomerase A)

Beyond the preview

Go deeper on Haporine-S (cyclosporine).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haporine-S (cyclosporine).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call